Stock listing

IMC Stock Price, News, Filings & Events — Immuron Limited

Selected listing: IMC · ASX · AUD · AU

This page tracks Immuron Limited's IMC:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMC:ASX. IMC:ASX is the stock-level entry point for investors researching Immuron Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Immuron Limited is a public company traded on the Australian market under the ticker IMC. The company has a market capitalization of approximately AUD 8.55 million. Immuron focuses on developing therapies for various health conditions, leveraging its proprietary technology and research.

IMC:ASXAUDAUUpdated September 11, 2026
Immuron Limited logo
Ticker
IMC:ASX
Asset type
Stock
Market cap
$13.4M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
ASX
Currency
AUD

Immuron Limited IMC:ASX stock context

This page tracks Immuron Limited's IMC:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMC:ASX. IMC:ASX is the stock-level entry point for investors researching Immuron Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Immuron Limited is a public company traded on the Australian market under the ticker IMC. The company has a market capitalization of approximately AUD 8.55 million. Immuron focuses on developing therapies for various health conditions, leveraging its proprietary technology and research.

Latest news from Immuron Limited

All Immuron Limited news →

Research Immuron Limited

Alternate listings